Press releases

Apr 15, 2010

Boston Scientific to Immediately Resume Distribution of COGNIS® CRT-Ds and TELIGEN® ICDs in the U.S.

Company is positioned to fully meet customer demand for COGNIS and TELIGEN within 24 hours
Apr 15, 2010

Boston Scientific to Webcast Conference Call Discussing First Quarter Financial Results

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2010...
Mar 18, 2010

FDA Advisory Panel Unanimously Recommends Expanded Indication for Boston Scientific's Heart Failure Devices Based on Landmark MADIT-CRT Trial

Company's CRT-Ds recommended for asymptomatic and mild heart failure patients
Mar 16, 2010

Boston Scientific Completes Enrollment in PLATINUM Trials for Small Vessels and Long Lesions

Trials to evaluate small vessel and long lesion versions of platinum chromium PROMUS® Element™ Stent System
Mar 15, 2010

Study Shows Superior Efficacy for TAXUS® Express® Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack

Boston Scientific applies to FDA for expanded indications for TAXUS Express and TAXUS® Liberte® Stents in AMI patients

Show per page

Top